Leidos Holdings, Inc. (NYSE:LDOS) Receives $160.27 Consensus PT from Analysts

Leidos Holdings, Inc. (NYSE:LDOS) has received an average recommendation of “Hold” from the seventeen ratings firms that are currently covering the stock, MarketBeat.com reports. Ten equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $162.9333.

Several research firms recently weighed in on LDOS. Weiss Ratings downgraded shares of Leidos from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, June 8th. Stifel Nicolaus dropped their price target on shares of Leidos from $205.00 to $193.00 and set a “hold” rating on the stock in a research report on Wednesday, May 6th. TD Cowen upped their price target on shares of Leidos from $115.00 to $135.00 and gave the stock a “hold” rating in a research note on Friday, August 7th. The Goldman Sachs Group decreased their price objective on shares of Leidos from $152.00 to $132.00 and set a “neutral” rating for the company in a report on Wednesday, August 12th. Finally, Jefferies Financial Group reissued a “hold” rating and set a $145.00 target price on shares of Leidos in a report on Sunday, August 9th.

Insider Buying and Selling

In other news, Director Noel B. Geer sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $140.66, for a total transaction of $1,406,600.00. Following the sale, the director owned 34,274 shares in the company, valued at $4,820,980.84. The trade was a 22.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.77% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. Bryn Mawr Trust Advisors LLC boosted its stake in shares of Leidos by 4.8% during the 4th quarter. Bryn Mawr Trust Advisors LLC now owns 1,337 shares of the aerospace company’s stock valued at $241,000 after buying an additional 61 shares during the period. Cullen Frost Bankers Inc. raised its holdings in shares of Leidos by 19.4% during the fourth quarter. Cullen Frost Bankers Inc. now owns 381 shares of the aerospace company’s stock worth $69,000 after acquiring an additional 62 shares in the last quarter. Keybank National Association OH boosted its position in Leidos by 3.6% during the fourth quarter. Keybank National Association OH now owns 1,855 shares of the aerospace company’s stock valued at $335,000 after purchasing an additional 65 shares during the last quarter. N.E.W. Advisory Services LLC grew its stake in Leidos by 17.2% in the fourth quarter. N.E.W. Advisory Services LLC now owns 469 shares of the aerospace company’s stock valued at $85,000 after purchasing an additional 69 shares in the last quarter. Finally, Glenmede Investment Management LP grew its stake in Leidos by 3.2% in the third quarter. Glenmede Investment Management LP now owns 2,240 shares of the aerospace company’s stock valued at $423,000 after purchasing an additional 69 shares in the last quarter. Institutional investors and hedge funds own 76.12% of the company’s stock.

Leidos Trading Up 0.3%

NYSE LDOS opened at $141.84 on Monday. The company has a market capitalization of $17.80 billion, a price-to-earnings ratio of 13.23, a price-to-earnings-growth ratio of 2.06 and a beta of 0.52. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.63 and a quick ratio of 1.60. Leidos has a 12 month low of $98.86 and a 12 month high of $205.77. The company’s fifty day moving average price is $117.10 and its two-hundred day moving average price is $141.19.

Leidos (NYSE:LDOS) last released its earnings results on Tuesday, August 4th. The aerospace company reported $3.26 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.35. Leidos had a return on equity of 30.81% and a net margin of 7.80%.The company had revenue of $4.56 billion for the quarter, compared to the consensus estimate of $4.44 billion. During the same quarter last year, the business posted $3.21 EPS. Leidos’s quarterly revenue was up 7.2% compared to the same quarter last year. Leidos has set its FY 2026 guidance at 12.200-12.500 EPS. As a group, research analysts predict that Leidos will post 12.38 earnings per share for the current fiscal year.

Leidos Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Tuesday, September 15th will be issued a $0.43 dividend. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $1.72 annualized dividend and a dividend yield of 1.2%. Leidos’s dividend payout ratio is currently 16.04%.

Leidos declared that its Board of Directors has initiated a share buyback program on Friday, July 31st that authorizes the company to repurchase 20,000,000 outstanding shares. This repurchase authorization authorizes the aerospace company to repurchase shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s leadership believes its stock is undervalued.

About Leidos

Leidos is an American technology and engineering company that provides services and solutions to government and commercial customers, with a strong focus on national security, defense, intelligence, and civil government markets. The company delivers systems integration, engineering, cybersecurity, software development, data analytics, cloud migration and managed IT services, as well as mission support for complex programs. Leidos’ work spans areas such as C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance), secure communications, sensors and systems engineering, and health IT solutions for public-sector healthcare programs.

Leidos traces its corporate roots to Science Applications International Corporation (SAIC) and emerged as an independent, publicly traded company following a corporate separation in 2013.